parp inhibitors and the embraca study of talazoparib in brca-related metastatic breast cancer
Published 9 years ago • 860 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
3:52
the phase 3 embraca study of talazoparib in brca-related metastatic breast cancer
-
3:45
current research into treatments for brca-related breast cancer and the phase 3 embraca trial
-
3:58
brca breast cancer: the advent of parp inhibitors
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
4:59
future role of parp inhibition in brca breast cancer
-
3:31
distinguishing between parp inhibitors in breast cancer
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
1:12
dr. joanne blum on the function of talazoparib in locally advanced and/or metastatic breast cancer
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
2:47
embraca: results of talazoparib vs chemotherapy relative to prior ct in patients with advanced b...
-
4:19
treating brca breast cancer with parp inhibition
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
5:19
parp inhibitors for brca-associated tnbc
-
4:10
the embraca trial for advanced breast cancer, a new parp inhibitor
-
2:59
parp inhibitors for metastatic breast cancer